These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 12426830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents].
    Beitzke A, Schuchlenz H, Beitzke M, Gamillscheg A, Stein HI, Zartner P.
    Z Kardiol; 2002 Sep; 91(9):693-700. PubMed ID: 12448068
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 5. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW, Reeder GS, Lennon RJ, Slusser JP, Freund MA, Cabalka AK, Cetta F, Hagler DJ.
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH, Bertog SC, Momberger J, Franke J, Hofmann I, Renkhoff K, Joy S, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Outcomes after Device Closure with Transseptal Puncture and Standard Technique in Patients with Patent Foramen Ovale and Ischemic Events.
    Moon J, Kang WC, Kim S, Kim MG, Oh PC, Park YM, Chung WJ, Choi DY, Lee JY, Lee YB, Hwang HY, Ahn T.
    J Interv Cardiol; 2016 Aug; 29(4):400-5. PubMed ID: 27282763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transseptal technique of percutaneous PFO closure results in persistent interatrial shunting.
    Tande AJ, Knickelbine T, Chavez I, Mooney MR, Poulose A, Harris KM.
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):295-300. PubMed ID: 15880797
    [Abstract] [Full Text] [Related]

  • 16. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, DeLodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabrò RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Marco Bonifati D, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Tomelleri G, Spalloni A, Giorli E, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Piras V, Rasura M, Simone AM, Gamba M, Cerrato P, Zedde ML, Micieli G, Melis M, Massucco D, Guido D, De Giuli V, Bonaiti S, D'Amore C, La Starza S, Iacoviello L, Padovani A, Italian Project on Stroke in Young Adults (IPSYS) Investigators.
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, Webb G, McLaughlin PR.
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [Abstract] [Full Text] [Related]

  • 18. Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.
    Schwerzmann M, Windecker S, Wahl A, Nedeltchev K, Mattle HP, Seiler C, Meier B.
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):490-5. PubMed ID: 15558761
    [Abstract] [Full Text] [Related]

  • 19. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS, Richter C, Otto J, Himmrich L, Schnabel R, Kampmann C, Rupprecht HJ, Marx J, Hommel G, Münzel T, Horstick G.
    Int J Cardiol; 2009 May 01; 134(1):33-41. PubMed ID: 18715659
    [Abstract] [Full Text] [Related]

  • 20. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M, Banerjee S, Brilakis ES.
    Cardiovasc Revasc Med; 2010 May 01; 11(1):63-6. PubMed ID: 20129363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.